{
    "nctId": "NCT02432118",
    "briefTitle": "Radiofrequency-Guided Localization in Patients With Abnormal Breast Tissue Undergoing Lumpectomy",
    "officialTitle": "A Feasibility Study of Radiofrequency Identification (RFID) Localization of Breast Lesions",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Neoplasm",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Localization success, defined as the surgical target visualized in the removed specimen AND the RFID tag removed from the patient's breast",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Have had stereotactic or ultrasound-guided biopsy with marker placement\n* Have a lesion or biopsy marker that is visible under ultrasound\n* Have a surgical target =\\< 6 cm from the skin when lying supine\n* Have a discreet surgical target\n* Have a lesion in which the center/focal area is defined\n* Have the ability to understand and the willingness to sign a written informed consent document\n* Eastern Cooperative Oncology Group (ECOG)/Karnofsky performance status will not be used as an inclusion criterion\n* Ability to understand and the willingness to sign a written informed consent document\n\nExclusion Criteria:\n\n* Require more than one localization needle for localization of the surgical target (bracket localization)\n* Have undergone previous open surgical biopsy, lumpectomy, or mastectomy in the operative breast\n* Have a prosthesis/implant in the operative breast\n* Have a cardiac pacemaker or defibrillator device\n* Be contraindicated for surgery\n* Be pregnant",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}